Nanotechnology News and Research

RSS

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

Roche and IBM announced today an agreement to develop a nanopore-based sequencer that will directly read and decode human DNA quickly and efficiently. Focused on advancing IBM's recently published "DNA Transistor" technology, the collaboration will take advantage of IBM's leadership in microelectronics, information technology and computational biology and Roche's expertise in medical diagnostics and genome sequencing.

1 Jul 2010

Novel method of encapsulating gases, liquids and solids using miniature bubbles

Researchers from University College London have won a £25,000 prize for developing technology that could be used to improve medical imaging, the targeted delivery of drugs and much more.

29 Jun 2010

BIND Biosciences announces $12.4 million Series C-1 financing

BIND Biosciences, Inc. (BIND), a privately held biopharmaceutical company developing best in class therapeutics based on its proprietary targeted nanotechnology platform, announced today that it has secured a $12.4 Million Series C-1 financing. This financing included all of BIND's current investors (including Polaris Venture Partners, Flagship Ventures, ARCH Venture Partners, NanoDimension and DHK Investments) as well as a new venture investor, Endeavour Vision, and private investors.

29 Jun 2010

New diagnostic tool may help detect HPV and other viruses

A cluster of carbon nanotubes coated with a thin layer of protein-recognizing polymer form a biosensor capable of using electrochemical signals to detect minute amounts of proteins, which could provide a crucial new diagnostic tool for the detection of a range of illnesses, a team of Boston College researchers report in the journal Nature Nanotechnology.

29 Jun 2010

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..

29 Jun 2010

MagForce's Nano-Cancer therapy receives European regulatory approval

Following two decades of intensive research and development efforts, MagForce Nanotechnologies AG, a Berlin-based medical technology company founded in 1997, has received European regulatory approval for its Nano-Cancer® therapy.

28 Jun 2010

Aphios awarded US patent for process to formulate polymeric microspheres, nanospheres

Aphios Corporation today announced that it was awarded United States Patent No. 7,708,915 B2 for "Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein," granted May 04, 2010. This invention is an improved process to formulate polymeric microspheres and nanospheres, and encapsulate therapeutic proteins or other useful substances, and a polymer microspheres/nanospheres apparatus.

24 Jun 2010

imec researchers demonstrate biosensors that detect extremely low concentrations of disease markers

Researchers at the nanotechnology research centre imec have demonstrated biosensors based on novel nanostructure geometries that increase the sensitivity and allow to detect extremely low concentrations of specific disease markers. This paves the way to early diagnostics of for example cancer by detecting low densities of cancer markers in human blood samples.

23 Jun 2010

Mayo Clinic, University of Illinois announce strategic alliance for technology-based health care

Mayo Clinic and the University of Illinois at Urbana-Champaign are announcing a strategic alliance designed to promote a broad spectrum of collaborative research, development of new technologies and clinical tools, and design and implementation of novel education programs. Both parties recently signed an agreement establishing the formal relationship.

23 Jun 2010

NTU, Technion announce new collaboration to jointly offer PhD programme

Singapore's leading science and technology university, Nanyang Technological University, and Israel's number one university, Technion-Israel Institute of Technology, today announced a new collaboration to jointly offer a Doctor of Philosophy programme.

22 Jun 2010

Celator announces expansion of research agreement with Cephalon

Celator Pharmaceuticals today announced that it has expanded its research agreement with Cephalon, Inc.. The research agreement provides for the utilization of Celator's proprietary technology in an ongoing drug development and life-cycle management program at Cephalon.

22 Jun 2010

Effects of periodic constrictions on drift, diffusion in systems experiencing driving force

An understanding of particle diffusion in the presence of constrictions is essential in fields as diverse as drug delivery, cellular biology, nanotechnology, materials engineering, and spread of pollutants in the soil. When a driving force is applied, displacement of particles occurs as well as diffusion. A paper in the Journal of Chemical Physics, which is published by the American Institute of Physics (AIP), quantifies the effects of periodic constrictions on drift and diffusion in systems experiencing a driving force.

21 Jun 2010

Gary and Mary West Foundation announces $25M commitment to West Wireless Health Institute

The Gary and Mary West Foundation today announced a $25 million commitment to enable the West Wireless Health Institute (WWHI) to amplify its aggressive recruitment of world class engineering talent and accelerate its mission on a national and global scale. The additional funding comes on the heels of a $20 million grant announced last month, and brings the total support provided by the foundation to nearly $100 million since the Institute's inception in March 2009.

19 Jun 2010

ActiveCare, Vista Therapeutics announce strategic relationship to develop Nano Biosensors for seniors

ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.

18 Jun 2010

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.

15 Jun 2010

New report on beneficial effects of nanotechnology innovation on human health, environment

The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,

14 Jun 2010

NJIT biomedical engineer awarded $1.3M grant to develop better ways to help stroke patients

Helping stroke patients regain use of their hands and arms through innovative robotic and virtual reality-based video game therapies is the focal point of NJIT Associate Professor Sergei Adamovich, a biomedical engineer. Thanks to a $1.3 million grant from the National Institutes of Health, Adamovich is developing better ways to rehabilitate people who have lost control of their hands, fingers, shoulders and elbows.

11 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

Leonardo Biosystems receives $2.5M grant to accelerate commercialization of new technologies

Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies. Leonardo Biosystems, co-founded by prominent nanoscientist Dr. Mauro Ferrari, professor at the University of Texas, and Arrowhead's, CEO Dr. Christopher Anzalone, is engineering a multi-stage drug delivery platform to improve the effectiveness of drug therapy, particularly for cancer.

7 Jun 2010

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

At the annual meeting of the American Urological Association, data using the Nanosphere Verisens™ ultra-sensitive PSA assay (research use only) will be highlighted as one of less than 40 abstracts that were singled out by the Association for a special session for journalists.

3 Jun 2010

Nanotechnology News and Research

Roche, IBM announce agreement to develop nanopore-based sequencer for decoding human DNA

Novel method of encapsulating gases, liquids and solids using miniature bubbles

BIND Biosciences announces $12.4 million Series C-1 financing

New diagnostic tool may help detect HPV and other viruses

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

MagForce's Nano-Cancer therapy receives European regulatory approval

Aphios awarded US patent for process to formulate polymeric microspheres, nanospheres

imec researchers demonstrate biosensors that detect extremely low concentrations of disease markers

Mayo Clinic, University of Illinois announce strategic alliance for technology-based health care

NTU, Technion announce new collaboration to jointly offer PhD programme

Celator announces expansion of research agreement with Cephalon

Effects of periodic constrictions on drift, diffusion in systems experiencing driving force

Gary and Mary West Foundation announces $25M commitment to West Wireless Health Institute

ActiveCare, Vista Therapeutics announce strategic relationship to develop Nano Biosensors for seniors

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

New report on beneficial effects of nanotechnology innovation on human health, environment

NJIT biomedical engineer awarded $1.3M grant to develop better ways to help stroke patients

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Leonardo Biosystems receives $2.5M grant to accelerate commercialization of new technologies

Data on Nanosphere Verisens PSA assay to be presented at AUA annual meeting

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News